All Posts By

Smartkarma Daily Briefs

Daily Brief ECM: ECM Weekly (14th Jan 2024) – Samsung and more

By | Daily Briefs, ECM

In today’s briefing:

  • ECM Weekly (14th Jan 2024) – Samsung, Lasertec, Ayala, Indigo, Amer, IPO Pipeline, 2023 Performance


ECM Weekly (14th Jan 2024) – Samsung, Lasertec, Ayala, Indigo, Amer, IPO Pipeline, 2023 Performance

By Sumeet Singh

  • Aequitas Research puts out a weekly update on the deals that were covered by the team recently along with updates for upcoming IPOs.
  • On the IPO front, a number of large filings over the holidays is somewhat positive for 2024 prospects.
  • On the placement front, 2024 picked up where 2023 left off, with Samsung Electronics (005930 KS) leading the way.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Event-Driven: Fuji Soft (9749 JP): A Potential Privatisation Faces Challenges and more

By | Daily Briefs, Event-Driven

In today’s briefing:

  • Fuji Soft (9749 JP): A Potential Privatisation Faces Challenges
  • Index Rebalance & ETF Flow Recap: HSI, LQ45, FXI, 2823 HK, SENSEX
  • (Mostly) Asia-Pac Weekly Risk Arb Wrap: TDCX, Orecorp, T&K Toka, Taisho Pharma, Benesse, IJTT
  • OCI Holdings Plans to Acquire a 27% In Hanmi Science – To Spark a Family Feud?
  • Last Week in Event SPACE: Furuya Metal, Visional, Wilmar, Samsung Electronics, ViinFast/Vingroup
  • Weekly Deals Digest (14 Jan) – T&K Toka, Fuji Soft, Taisho, Benefit One, IRC, Weiqiao, Amer, Ola


Fuji Soft (9749 JP): A Potential Privatisation Faces Challenges

By Arun George

  • Fuji Soft Inc (9749 JP) has disclosed that in response to a request from 3D Investment Partners, it has received non-binding privatisation proposals from several private equity funds. 
  • A privatisation proposal would facilitate the exit of 3D, the largest shareholder representing 21.45% of outstanding shares, which has waged an activist campaign since 2022. 
  • A binding privatisation proposal is challenging as the shares have hit a ten-year high, lofty multiple, and the Board seems to prefer its corporate value enhancement measures.

Index Rebalance & ETF Flow Recap: HSI, LQ45, FXI, 2823 HK, SENSEX

By Brian Freitas


(Mostly) Asia-Pac Weekly Risk Arb Wrap: TDCX, Orecorp, T&K Toka, Taisho Pharma, Benesse, IJTT

By David Blennerhassett


OCI Holdings Plans to Acquire a 27% In Hanmi Science – To Spark a Family Feud?

By Douglas Kim

  • After the market close on 12 January, OCI Holdings (010060 KS) announced that it plans to acquire a 27.03% stake in Hanmi Science (008930 KS) for 770 billion won. 
  • Through this investment and integration between OCI Holdings and Hanmi Science, the OCI Group and Hanmi Pharmaceutical Group plans to establish a joint management system.
  • This deal between OCI Holdings and Hanmi Science is not over and it could lead to an M&A fight for the control of Hanmi Science by its family members. 

Last Week in Event SPACE: Furuya Metal, Visional, Wilmar, Samsung Electronics, ViinFast/Vingroup

By David Blennerhassett


Weekly Deals Digest (14 Jan) – T&K Toka, Fuji Soft, Taisho, Benefit One, IRC, Weiqiao, Amer, Ola

By Arun George


💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Macro: The Weekly Market Monitor – Chinese Equities Out and more

By | Daily Briefs, Macro

In today’s briefing:

  • The Weekly Market Monitor – Chinese Equities Out, Bitcoin In!


The Weekly Market Monitor – Chinese Equities Out, Bitcoin In!

By Jeroen Blokland

  • After a ten-year struggle, US spot Bitcoin ETFs have been approved, closing one of the most entertaining and remarkable (what regulator gets hacked in the process) ETF races ever.
  • US inflation came in hotter than expected, but unlike previous months, underlying data was pretty benign, with one measure of headline CPI dropping below 2% for the first time in 3.5 years.
  • Chinese equities are out. And not just by sentiment-driven short-term investors. Meanwhile, Japanese stocks are on fire, powering ahead by more than 6% since the start of this year.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Equity Bottom-Up: TSMC Finishes 2023 With A Flourish and more

By | Daily Briefs, Equity Bottom-Up

In today’s briefing:

  • TSMC Finishes 2023 With A Flourish
  • Genting Singapore: A Surprising Value Buy at $1.0l Sgd Driven by Post Covid Catalysts Ahead Die 2024
  • Korean Air: European Approval for Asiana Merger Reportedly Imminent
  • China Healthcare Weekly (Jan.12) – Mainstream R&D Trend, Innovent, BeiGene, Sirnaomics, ImmuneOnco


TSMC Finishes 2023 With A Flourish

By William Keating

  • Q423 revenues amounted to NT$625,529. In US$ terms, using TSMC’s projected exchange rate of 32, this translates to  $19.55 billion, a ~13% increase QoQ, and a 2% decrease YoY.
  • FY 2023 revenues amounted to NT$2,161.74 billion, down 4.5% YoY. In US$ terms, this amounted to $69.1 billion, an 8.8% decrease YoY and the first such YoY decrease since 2009
  • While we foresee Q124 revenues being down 5-10% QoQ, we expect full year 2024 revenues to grow in the range of 5-10% YoY. 

Genting Singapore: A Surprising Value Buy at $1.0l Sgd Driven by Post Covid Catalysts Ahead Die 2024

By Howard J Klein

  • Parent Genting  Berhad Malaysia flagship properties doing well but many  of its global holdings spur questions about asset allocation strategy.
  • Genting Singapore, its integrated resort property Sentosa presents a strong buy story not only because it is  undervalued here but because its prospects post covid  are strong.
  • GB’s US footprint by  contrast poses questions  about the  hurdle rate of those huge investments to date given the intense competitive pressures in  mature gaming  markets.

Korean Air: European Approval for Asiana Merger Reportedly Imminent

By Neil Glynn

  • Reuters reported on the Friday that the European Commission is to accept concessions of four European route divestitures and the sale of Asiana’s cargo business.
  • The EC had set a preliminary decision deadline of 14 February.
  • US and Japanese approvals are still required, while it remains to be seen who might acquire Asiana Cargo.

China Healthcare Weekly (Jan.12) – Mainstream R&D Trend, Innovent, BeiGene, Sirnaomics, ImmuneOnco

By Xinyao (Criss) Wang

  • The entire R&D cycle involves multi-party cooperation, leveraging one’s strengths. So, it is not difficult to understand some of the choices made by domestic pharmaceutical companies (e.g. Innovent, BeiGene).
  • Due to outdated technology, investment value of Sirnaomics is low, which means the likelihood of the company being acquired is also not high. We remain conservative about the outlook. 
  • ImmuneOnco’s stock price has performed much better-than-expected after IPO on HKEX. However, the endgame of ImmuneOnco’s market value could be only about RMB1.5 billion, which means large potential downside ahead.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief South Korea: Hanmi Science, Korean Air Lines, Samsung Electronics and more

By | Daily Briefs, South Korea

In today’s briefing:

  • OCI Holdings Plans to Acquire a 27% In Hanmi Science – To Spark a Family Feud?
  • Korean Air: European Approval for Asiana Merger Reportedly Imminent
  • ECM Weekly (14th Jan 2024) – Samsung, Lasertec, Ayala, Indigo, Amer, IPO Pipeline, 2023 Performance
  • Last Week in Event SPACE: Furuya Metal, Visional, Wilmar, Samsung Electronics, ViinFast/Vingroup


OCI Holdings Plans to Acquire a 27% In Hanmi Science – To Spark a Family Feud?

By Douglas Kim

  • After the market close on 12 January, OCI Holdings (010060 KS) announced that it plans to acquire a 27.03% stake in Hanmi Science (008930 KS) for 770 billion won. 
  • Through this investment and integration between OCI Holdings and Hanmi Science, the OCI Group and Hanmi Pharmaceutical Group plans to establish a joint management system.
  • This deal between OCI Holdings and Hanmi Science is not over and it could lead to an M&A fight for the control of Hanmi Science by its family members. 

Korean Air: European Approval for Asiana Merger Reportedly Imminent

By Neil Glynn

  • Reuters reported on the Friday that the European Commission is to accept concessions of four European route divestitures and the sale of Asiana’s cargo business.
  • The EC had set a preliminary decision deadline of 14 February.
  • US and Japanese approvals are still required, while it remains to be seen who might acquire Asiana Cargo.

ECM Weekly (14th Jan 2024) – Samsung, Lasertec, Ayala, Indigo, Amer, IPO Pipeline, 2023 Performance

By Sumeet Singh

  • Aequitas Research puts out a weekly update on the deals that were covered by the team recently along with updates for upcoming IPOs.
  • On the IPO front, a number of large filings over the holidays is somewhat positive for 2024 prospects.
  • On the placement front, 2024 picked up where 2023 left off, with Samsung Electronics (005930 KS) leading the way.

Last Week in Event SPACE: Furuya Metal, Visional, Wilmar, Samsung Electronics, ViinFast/Vingroup

By David Blennerhassett


💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Singapore: Genting Singapore and more

By | Daily Briefs, Singapore

In today’s briefing:

  • Genting Singapore: A Surprising Value Buy at $1.0l Sgd Driven by Post Covid Catalysts Ahead Die 2024


Genting Singapore: A Surprising Value Buy at $1.0l Sgd Driven by Post Covid Catalysts Ahead Die 2024

By Howard J Klein

  • Parent Genting  Berhad Malaysia flagship properties doing well but many  of its global holdings spur questions about asset allocation strategy.
  • Genting Singapore, its integrated resort property Sentosa presents a strong buy story not only because it is  undervalued here but because its prospects post covid  are strong.
  • GB’s US footprint by  contrast poses questions  about the  hurdle rate of those huge investments to date given the intense competitive pressures in  mature gaming  markets.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief China: BYD Electronics, ImmuneOnco Biopharmaceuticals (Shanghai) and more

By | China, Daily Briefs

In today’s briefing:

  • Index Rebalance & ETF Flow Recap: HSI, LQ45, FXI, 2823 HK, SENSEX
  • China Healthcare Weekly (Jan.12) – Mainstream R&D Trend, Innovent, BeiGene, Sirnaomics, ImmuneOnco


Index Rebalance & ETF Flow Recap: HSI, LQ45, FXI, 2823 HK, SENSEX

By Brian Freitas


China Healthcare Weekly (Jan.12) – Mainstream R&D Trend, Innovent, BeiGene, Sirnaomics, ImmuneOnco

By Xinyao (Criss) Wang

  • The entire R&D cycle involves multi-party cooperation, leveraging one’s strengths. So, it is not difficult to understand some of the choices made by domestic pharmaceutical companies (e.g. Innovent, BeiGene).
  • Due to outdated technology, investment value of Sirnaomics is low, which means the likelihood of the company being acquired is also not high. We remain conservative about the outlook. 
  • ImmuneOnco’s stock price has performed much better-than-expected after IPO on HKEX. However, the endgame of ImmuneOnco’s market value could be only about RMB1.5 billion, which means large potential downside ahead.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Japan: Fuji Soft Inc, Taisho Pharmaceutical Holdin, T&K Toka Co Ltd, TSE Tokyo Price Index TOPIX and more

By | Daily Briefs, Japan

In today’s briefing:

  • Fuji Soft (9749 JP): A Potential Privatisation Faces Challenges
  • (Mostly) Asia-Pac Weekly Risk Arb Wrap: TDCX, Orecorp, T&K Toka, Taisho Pharma, Benesse, IJTT
  • Weekly Deals Digest (14 Jan) – T&K Toka, Fuji Soft, Taisho, Benefit One, IRC, Weiqiao, Amer, Ola
  • TSE’s Request for Disclosure About Parent-Subsidiary Listings Is an Improvement, Not a Solution


Fuji Soft (9749 JP): A Potential Privatisation Faces Challenges

By Arun George

  • Fuji Soft Inc (9749 JP) has disclosed that in response to a request from 3D Investment Partners, it has received non-binding privatisation proposals from several private equity funds. 
  • A privatisation proposal would facilitate the exit of 3D, the largest shareholder representing 21.45% of outstanding shares, which has waged an activist campaign since 2022. 
  • A binding privatisation proposal is challenging as the shares have hit a ten-year high, lofty multiple, and the Board seems to prefer its corporate value enhancement measures.

(Mostly) Asia-Pac Weekly Risk Arb Wrap: TDCX, Orecorp, T&K Toka, Taisho Pharma, Benesse, IJTT

By David Blennerhassett


Weekly Deals Digest (14 Jan) – T&K Toka, Fuji Soft, Taisho, Benefit One, IRC, Weiqiao, Amer, Ola

By Arun George


TSE’s Request for Disclosure About Parent-Subsidiary Listings Is an Improvement, Not a Solution

By Aki Matsumoto

  • Parent-Subsidiary listings present several problems: the disadvantages to parent company’s shareholders that drain subsidiary’s profits, the distortion of market capitalization between subsidiary and parent company, and independence of subsidiary’s management.
  • While it’s an improvement for TSE to ask companies to disclose their purpose and policy of listing subsidiaries and affiliates, it doesn’t ensure the complete independence of subsidiaries and affiliates.
  • More than 30% of listed companies are listed subsidiaries or affiliates. Investors are forced to look for investment targets while worrying about management independence in 70% of the companies.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Most Read: WuXi XDC Cayman , Posco DX, Shriram Finance , Zhongsheng Group, Wipro Ltd, Fujitsu Ltd, Fuji Soft Inc, Taiwan Semiconductor (TSMC) – ADR, Genting Singapore, BYD Electronics and more

By | Daily Briefs, Most Read

In today’s briefing:

  • HSCI Index Rebalance Preview and Stock Connect: Potential Changes in March
  • Index Rebalance & ETF Flow Recap: STAR50, SET50, AMFI, KOSDAQ150
  • Index Rebalance & ETF Flow Recap: HSCEI, HSCI, KRX New Deal, NIFTY50, NEXT50, CNXBANK
  • HSCEI Index Rebalance Preview: Zhongsheng (881 HK) Should Go This Time
  • SENSEX Index Rebalance Preview: Likely Wipro Deletion Opens an Index Spot
  • Fujitsu (6702 JP): Horizon Scandal Blows Up
  • Fuji Soft (9749 JP): A Potential Privatisation Faces Challenges
  • TSMC Finishes 2023 With A Flourish
  • Genting Singapore: A Surprising Value Buy at $1.0l Sgd Driven by Post Covid Catalysts Ahead Die 2024
  • Index Rebalance & ETF Flow Recap: HSI, LQ45, FXI, 2823 HK, SENSEX


HSCI Index Rebalance Preview and Stock Connect: Potential Changes in March

By Brian Freitas

  • We see 30 potential adds (including plenty of new listings) and 28 potential deletes (on market cap and liquidity) for the Hang Seng Composite Index in March.
  • We expect 26 stocks to be added to Southbound Stock Connect following the rebalance while 25 stocks could be deleted from the trading link and become Sell-only.
  • There are stocks that have a very high percentage of holdings via Stock Connect and there could be some unwinding prior to the stocks becoming Sell-only.

Index Rebalance & ETF Flow Recap: STAR50, SET50, AMFI, KOSDAQ150

By Brian Freitas


Index Rebalance & ETF Flow Recap: HSCEI, HSCI, KRX New Deal, NIFTY50, NEXT50, CNXBANK

By Brian Freitas

  • Posco DX (022100 KS) continues to drop following its section transfer from the KOSDAQ market to the KOSPI market. Short interest in the stock nearly halved in December.
  • There were big net inflows to China ETFs with creations in CSI 300 Index ETFs and redemptions in ETFs tracking the CSI 500 Index and CSI 1000 Index.
  • Creations continued in the iShares Emerging Markets ex China (EMXC US) ETF with units outstanding reaching a new high.

HSCEI Index Rebalance Preview: Zhongsheng (881 HK) Should Go This Time

By Brian Freitas

  • Zhongsheng Group (881 HK) pops up as a potential deletion yet again and a much lower rank raises the probability of deletion to just short of a near certainty.
  • With BeiGene (6160 HK) failing the Velocity Test for Tradeable Indexes, Zhongsheng Group (881 HK)‘s deletion from the index should result in China Unicom Hong Kong (762 HK)‘s inclusion. 
  • Estimated one-way turnover at the rebalance is 1.47% resulting in a one-way trade of HK$946m. Passives will need to trade over 2.5x ADV on both stocks.

SENSEX Index Rebalance Preview: Likely Wipro Deletion Opens an Index Spot

By Brian Freitas

  • Over a third of the way through the review period of the June rebalance, we see one potential index change with Wipro Ltd (WPRO IN) in deletion zone.
  • There are a bunch of stocks that could be added to the index as a replacement and price changes over the rest of the review period are important.
  • Passive trackers will need to trade over 1x ADV and over 7x of delivery volume on the index changes, so there will be decent impact on the stocks.

Fujitsu (6702 JP): Horizon Scandal Blows Up

By Scott Foster

  • The UK Post Office “Horizon Scandal” has blown up, putting Fujitsu’s computer system failure on the front pages and on the agenda of Parliament and Prime Minister Sunak.
  • Fujitsu UK has been awarded £6.8bn in public contracts since 2012. The Justice Secretary is  now talking about compensation for the enormous financial and personal damage caused.
  • Fujitsu’s share price is coming off a new all-time high reached in December. The amount of compensation and loss of potential future contracts is substantial but uncertain.

Fuji Soft (9749 JP): A Potential Privatisation Faces Challenges

By Arun George

  • Fuji Soft Inc (9749 JP) has disclosed that in response to a request from 3D Investment Partners, it has received non-binding privatisation proposals from several private equity funds. 
  • A privatisation proposal would facilitate the exit of 3D, the largest shareholder representing 21.45% of outstanding shares, which has waged an activist campaign since 2022. 
  • A binding privatisation proposal is challenging as the shares have hit a ten-year high, lofty multiple, and the Board seems to prefer its corporate value enhancement measures.

TSMC Finishes 2023 With A Flourish

By William Keating

  • Q423 revenues amounted to NT$625,529. In US$ terms, using TSMC’s projected exchange rate of 32, this translates to  $19.55 billion, a ~13% increase QoQ, and a 2% decrease YoY.
  • FY 2023 revenues amounted to NT$2,161.74 billion, down 4.5% YoY. In US$ terms, this amounted to $69.1 billion, an 8.8% decrease YoY and the first such YoY decrease since 2009
  • While we foresee Q124 revenues being down 5-10% QoQ, we expect full year 2024 revenues to grow in the range of 5-10% YoY. 

Genting Singapore: A Surprising Value Buy at $1.0l Sgd Driven by Post Covid Catalysts Ahead Die 2024

By Howard J Klein

  • Parent Genting  Berhad Malaysia flagship properties doing well but many  of its global holdings spur questions about asset allocation strategy.
  • Genting Singapore, its integrated resort property Sentosa presents a strong buy story not only because it is  undervalued here but because its prospects post covid  are strong.
  • GB’s US footprint by  contrast poses questions  about the  hurdle rate of those huge investments to date given the intense competitive pressures in  mature gaming  markets.

Index Rebalance & ETF Flow Recap: HSI, LQ45, FXI, 2823 HK, SENSEX

By Brian Freitas


💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Analytics and News
  • ✓ Events & Webinars



Daily Brief Industrials: International Consolidated Airlines Group, Arcosa , Controladora Vuela Cia De-A, FedEx Corp, FuelCell Energy , HEICO Corp, Cintas Corp, Plug Power Inc, Sunrun Inc, United Rentals and more

By | Daily Briefs, Industrials

In today’s briefing:

  • European Airlines – Bridging Quarterly 2024 Prospects Encourages with Fuel Tailwinds/Tight Supply
  • Arcosa Inc (ACA) – Friday, Oct 13, 2023
  • Global Airlines: Mexico’s Volaris Shows GTF Groundings Can Drive Higher Pricing
  • FedEx Corporation: The Road to Recovery – How They’re Overcoming Challenges! – Major Drivers
  • FuelCell Energy Inc.: Carbon Capture Advancements & Revenue Growth in 2024 – Major Drivers
  • HEICO Corporation: Exceptional Enthusiasm for Wencor – Why is it a Standout Acquisition? – Major Drivers
  • Cintas Corporation: Energy Efficiency Initiatives Driving Favorable Outcomes – What’s Next? – Major Drivers
  • Plug Power Inc.: Are Their Recent Struggles Just a Hurdle to Success? – Major Drivers
  • Sunrun Inc.: Expansion of Clean Energy Across the US – What’s the Future Outlook? – Major Drivers
  • United Rentals Inc.: Here Are The 3 Biggest Risks The Company Faces! – Major Drivers


European Airlines – Bridging Quarterly 2024 Prospects Encourages with Fuel Tailwinds/Tight Supply

By Neil Glynn

  • We are most ahead of consensus for IAG in 2024, and recognising Lufthansa’s highest-in-group double-digit capacity growth rate in 2024 may render its earnings most difficult to forecast/vulnerable to disappointment.
  • For AF-KLM 2024 seems a crucial year to demonstrate it can grow earnings in more challenging conditions if it is to increase confidence it can reach near-€4bn EBIT by 2028.
  • Delta reports 2023 results today, and its outlook commentary will be important to frame 1Q24 prospects on the Transatlantic, which should encourage that 2024 will prove resilient.

Arcosa Inc (ACA) – Friday, Oct 13, 2023

By Value Investors Club

Key points (machine generated)

  • Arcosa is a high-quality equity investment benefiting from secular trends and government spending, with underappreciated secondary businesses experiencing rapid growth.
  • The IRA tax credits are expected to act as a significant catalyst for Arcosa, pushing its numbers higher than anticipated.
  • Despite its strong balance sheet, excellent management, and successful capital allocation history, Arcosa has zero hedge fund ownership, making it an attractive opportunity.

This article is sourced from an online content aggregator through publicly available sources and is displayed below for general informational purposes only. This article was originally published 3 months ago on Value Investors Club.


Global Airlines: Mexico’s Volaris Shows GTF Groundings Can Drive Higher Pricing

By Neil Glynn

  • Mexico’s Volaris has announced its 1Q24 and FY24 capacity is likely to be down 16-18% yoy due to GTF engine inspections grounding aircraft.
  • However, on this reduced capacity, management anticipates a 31-33% EBITDAR margin, up from 26% in 2023, helped by fuel costs down c.9%. We model $1bn EBITDAR in 2024 (2023 $840m).
  • This dynamic has read across for many short/medium haul markets around the world has capacity constraints are likely to drive up pricing/earnings for affected carriers and also competitors.

FedEx Corporation: The Road to Recovery – How They’re Overcoming Challenges! – Major Drivers

By Baptista Research

  • FedEx Corporation delivered disappointing results as the company could not meet Wall Street’s revenue and earnings expectations.
  • Despite a 3% decline in total revenue, the enterprise achieved a 17% improvement in adjusted operating income and a 110 basis points expansion in adjusted margin compared to the previous year.
  • The Ground segment exhibited outstanding performance with a 57% increase in adjusted operating income and a remarkable 370 basis points expansion in adjusted margin.

FuelCell Energy Inc.: Carbon Capture Advancements & Revenue Growth in 2024 – Major Drivers

By Baptista Research

  • FuelCell Energy, Inc. delivered mixed results for the previous quarter, with revenues below the analyst consensus.
  • In the recently disclosed fourth quarter and full-year results, the company celebrates substantial progress in major projects, the evolution of solid oxide power generation, and electrolysis hydrogen platforms.
  • Collaborating with major corporations, such as ExxonMobil, Toyota, Pfizer, EDF Energy, and IBM, FuelCell has made substantial strides in carbon capture solutions, distributed hydrogen, microgrid development, and innovative collaborations using AI.

HEICO Corporation: Exceptional Enthusiasm for Wencor – Why is it a Standout Acquisition? – Major Drivers

By Baptista Research

  • HEICO Corporation delivered an all-around beat in the previous quarter, with operating income and net sales reaching unprecedented heights.
  • The fourth quarter of fiscal ’23 witnessed a remarkable 29% surge in consolidated operating income and a 54% increase in net sales compared to the same period in fiscal ’22.
  • The Flight Support Group achieved significant net sales of $601.7 million in the fourth quarter of fiscal year ’23, marking a 74% increase from the same period in fiscal year ’22.

Cintas Corporation: Energy Efficiency Initiatives Driving Favorable Outcomes – What’s Next? – Major Drivers

By Baptista Research

  • Cintas Corporation delivered a positive result and managed an all-around beat in the last quarter, reaching $2.38 billion compared to the previous year’s $2.1 billion.
  • The gross margin for the quarter reached $1.14 billion, marking an 11.6% increase from the previous year.
  • In this report, we have carried out a fundamental analysis of the historical financial statements of the company.

Plug Power Inc.: Are Their Recent Struggles Just a Hurdle to Success? – Major Drivers

By Baptista Research

  • Plug Power Inc.’s results were a major disappointment as the company failed to meet the revenue and earnings expectations both of Wall Street.
  • Difficulties arose due to plant downtimes, notably at the Tennessee facility, causing temporary outages across the hydrogen network.
  • Plug Power’s diversified business model is evident, with fourth-quarter revenue from new ventures expected to surpass traditional business revenue.

Sunrun Inc.: Expansion of Clean Energy Across the US – What’s the Future Outlook? – Major Drivers

By Baptista Research

  • Sunrun Inc. delivered a mixed result in the recent quarter, with revenues below market expectations but surpassed the analyst consensus regarding earnings.
  • The storage attachment rate surged to over 33% of installations in Q3, a significant rise from 15% at the beginning of the year.
  • Despite challenges in the Californian market due to policy changes, Sunrun launched its new add-on storage product for solar clients in California.

United Rentals Inc.: Here Are The 3 Biggest Risks The Company Faces! – Major Drivers

By Baptista Research

  • United Rentals, Inc. delivered an all-around beat in the most recent quarterly result, witnessing a substantial 23% year-over-year surge in total revenue, reaching an unprecedented $3.8 billion.
  • The company’s Adjusted EBITDA soared by 22%, achieving a third-quarter high of $1.85 billion, resulting in a margin exceeding 49%.
  • The strategic addition of personnel is highlighted as a key factor in successfully assimilating companies into United Rentals.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars